Santhera Pharmaceuticals

Switzerland
Liestal, Basel-Landschaft, Switzerland, 4410

Company profile

Santhera Pharmaceuticals company profile

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.

Business identity

Contact email
[email protected]
Phone number
+41 61 906 89 50
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2004-09-01, Month

Headquarters

Postal code
4410
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
14
Total equity funding
$145.2M
Last funding
Post IPO Debt / $13M / 2025-11-05
Last equity funding
Post IPO Equity / $5.4M
Investors
18
Lead investors
6
Founders
2
Articles
161
Exited on
2006-11-03

Founders and investors

Founders

Kristina SchmidtThomas Meier

Lead investors

Ares Life SciencesHighbridge Capital ManagementIdorsiaNGN CapitalPartners GroupYA Global Master SPV

Investors

BioMedPartnersDowHighbridge Capital ManagementIdorsiaPartners Group